StonvexLoading…
StonvexStonvexStonvexCore line items from RJET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $438.90M | $1.35B | $278.21M | $290.76M |
Operating Income | $54.20M | $168.30M | $-66.58M | $-168.19M |
Net Income | $26.90M | $76.20M | $-51.90M | $20.86M |
EPS (Diluted) | $0.58 | $1.87 | $-1.25 | $-3.68 |
Total Assets | $3.27B | $3.28B | $158.93M | $178.65M |
Total Liabilities | $1.91B | $1.95B | $211.57M | $219.93M |
Cash & Equivalents | $111.30M | $134.30M | $38.73M | $42.47M |
Free Cash Flow OCF − CapEx | $-35.30M | $-74.90M | $-39.63M | $-48.76M |
Shares Outstanding | 45.60M | 45.71M | 41.88M | 41.86M |